SCHEMBL9508845

SCHEMBL9508845

Cc1cc(F)ccc1Nc1nc(Nc2ccccc2C)c2cc(OCCN(C)C)ccc2n1

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9509672 0.95 HRH3 (0.46) SLC2A1
SCHEMBL9508852 0.85
SCHEMBL9511891 0.84 SLC2A1 (0.50) SLC2A1
SCHEMBL9508244 0.81 BTK (0.48)
SCHEMBL9509676 0.81
SCHEMBL9776763 0.78 SLC2A1 (0.68) SLC2A1
SCHEMBL9511859 0.78 SLC2A1 (0.52) SLC2A1
SCHEMBL9508947 0.78
Hydrochloric Acid SCHEMBL9811769 0.78 SLC2A1 (0.70) SLC2A1
Hydrochloric Acid SCHEMBL9508193 0.77 SLC2A1 (0.54) SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0404322-B1 QUINAZOLINE DERIVATIVES SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1993-09-22 EP claimed
US-5064833-A Substituted quinazoline derivatives for use in gastrointestinal diseases SMITHKLINE BEECHAM INTERCREDIT B.V. (GB) 1991-11-12 US claimed
EP-0404322-B1 QUINAZOLINE DERIVATIVES SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1993-09-22 EP disclosed
US-5064833-A Substituted quinazoline derivatives for use in gastrointestinal diseases SMITHKLINE BEECHAM INTERCREDIT B.V. (GB) 1991-11-12 US disclosed
EP-0404322-A1 Quinazoline derivatives SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1990-12-27 EP disclosed